Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × sargramostim × Clear all

Sponsor

Conditions

Leukemia 16 Lymphoma 10 Leukemia, Myeloid, Acute 9 Breast Neoplasms 9 Neuroblastoma 8 Myelodysplastic Syndromes 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Melanoma 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Ganglioneuroblastoma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Hodgkin Disease 2 Gliosarcoma 2

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 AZD 6244 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 copanlisib 1 cediranib 1 alectinib 1 Vorinostat 1 Vemurafenib 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Bortezomib 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡